Skip to content

IONIS PHARMACEUTICALS, INC.

IONS

CIK 0000874015

← back to feed
Revenue (TTM)
$986.47M
+33.8% YoY Q1 Apr 2026
Net Income (TTM)
−$244.52M
−119.8% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.59
−113.6% YoY Q1 Apr 2026
Gross Margin
98.9%
Q1 Apr 2026
Operating Margin
-28.9%
Q1 Apr 2026
Net Margin
-24.8%
Q1 Apr 2026
Free Cash Flow (TTM)
−$1.28B
Q1 Apr 2026
Cash
$173.38M
Q1 Apr 2026
Total Debt
$1.76B
Q1 Apr 2026
Shares Outstanding
165.26M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings